An Update on Zolpidem Abuse and Dependence

@article{VictorriVigneau2014AnUO,
  title={An Update on Zolpidem Abuse and Dependence},
  author={C. Victorri-Vigneau and M. Gerardin and M. Rousselet and M. Guerlais and M. Grall-Bronnec and P. Jolliet},
  journal={Journal of Addictive Diseases},
  year={2014},
  volume={33},
  pages={15 - 23}
}
In 2004, the health authorities (French National Agency for Medicines and Health Products Safety—ANSM) modified the summary of zolpidem characteristics. Particularly it now includes the sentence “a pharmacodependence may materialize.” The current article aims to show that despite this modification, zolpidem continues to be associated with problematic drug use, as the official system (Center for Evaluation and Information on Pharmacodependence—Addictovigilance network) providing information on… Expand
An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
TLDR
Assessing datasets of adverse drug reactions provided by the European Medicines Agency through the EudraVigilance system suggests current data may only represent a gross underestimate of the real prevalence of Z-drug misuse. Expand
The Pharmacovigilance Syndrome.
TLDR
It can’t be sure if any of the patients actually had serotonin syndrome, whether the patients were exposed to the target drug or drugs in question, or whether the drug(s) actually caused the serotonin syndrome if it happened, as the authors correctly point out, data derived from pharmacovigilance systems has important limitations. Expand
Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study
TLDR
The objective of this study was to evaluate the impact of the implementation of secure prescription pads on the prescription of zolpidem and other sedative medications (zopiclone, benzodiazepines and antihistamines) in long‐term users of zolediazepine and associated factors. Expand
Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients
TLDR
The present study shows a very low prevalence of DILI among high-dose ZLM abusers, and the prevalence of hypertransaminasemia was in line with general population. Expand
Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development
TLDR
Current understanding and definitions of drug dependence and withdrawal are presented which are also relevant and important features of addiction, though not the same, and a first compilation of withdrawal syndromes for CNS drugs is presented. Expand
‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse
  • L. Orsolini, S. Chiappini, +5 authors U. Volpe
  • Medicine
  • Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2021
TLDR
According to the findings, zolpidem should be prescribed with the same caution as BZDs, especially in patients with a history of drug abuse or in the elderly, and monitoring of zolPidem use in selected populations is warranted. Expand
The French addictovigilance network clinical assessment: Z-drugs, true false twins
TLDR
The results were in favour of a higher prevalence of physical and compulsive signs of dependence and of harmful consequences of dependence, with zolpidem than with zopiclone. Expand
French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol
TLDR
The objective of the ZOlpidem and the Reinforcement of the Regulation of prescription Orders (ZORRO) study is to evaluate the overall impact of the new regulatory framework requiring zolpidem to be prescribed on special secure prescription pads. Expand
Misuse of Benzodiazepines in France
TLDR
Despite national interventions and strategies to reduce all benzodiazepine misuse, their consumption remains at a high level and the next challenge will be to find innovative and creative solutions with guaranties limiting switches to other inappropriate drugs. Expand
A case of zolpidem dependence with extremely high daily doses
TLDR
The case of a zolpidem‐dependent patient who consumed it in quantities of 2400 mg/day, a quantity not reported anywhere in literature and around 240 times more than its usual prescribed daily dosage is presented. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 43 REFERENCES
Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.
TLDR
This study adds to the growing evidence that zolpidem has the potential for abuse and dependence and the French drug monograph has been modified by the French Health Authorities. Expand
[Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997].
TLDR
The data showed a slight decrease in heroin consumption as well as a marked increase in the use of maintenance treatments for serious opioid addiction, and the association between benzodiazepines and buprenorphine (Subutex) should consequently be studied, whether bupenorphine is being used illicitly or prescribed as a maintenance treatment. Expand
Dependence on zolpidem
TLDR
It is suggested that zolpidem at high doses might lose its selectivity on GABAA receptors and exhibit the same pharmacologic effects as classical benzodiazepines as in this case. Expand
Quetiapine treatment of zolpidem dependence.
TLDR
The case of Mr. A, a 52-year-old man with a lifelong history of substance use disorders who developed a dependence on zolpidem, which was successfully treated with quetiapine, is reported, which is a relatively safe drug compared to conventional hypnotics. Expand
Dependence on zolpidem: two case reports of detoxification with flumazenil infusion.
TLDR
This work describes two cases of zolpidem dependence that were detoxified by the use of flumazenil infusion and may represent an alternative to detoxification treatment by employing a tapering approach, or by replacement therapy with BDZs with a long half-life, particularly where patients are hard to treat or have low compliance to treatment. Expand
[Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
TLDR
The main trends observed were an increasing interest for opioid maintenance treatment by methadone versus buprenorphine high dosage, some changes in illicit drugs uses and changes in the grading of the most consumpted benzodiazepines (decrease in flunitrazepam consumption and increase in clonazepam Consumption). Expand
Zolpidem dependence and withdrawal seizure--report of two cases.
TLDR
Clinicians should pay close attention to the potential of zolpidem tolerance, abuse and dependence and the possibility of withdrawal seizure cannot be excluded especially at high doses. Expand
Survey of Forged Prescriptions to Investigate Risk of Psychoactive Medications Abuse in France
TLDR
Analysis of data collected from community pharmacies in the OSIAP (Ordonnances Suspectes Indicateur d’Abus et de Pharmacodépendance) survey gives information about patterns of diversion of medication in France and defines different profiles of forged prescriptions. Expand
[Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction].
TLDR
Analysis of information concerning multiple drug addiction, illicit behaviors and use of the venous route by maintenance treatment patients included in the October 1998 survey of the OPPIDUM program found patients maintained by methadone appeared to be more unbalanced and in more precarious condition than subjects treated in specialized care centers. Expand
Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure.
TLDR
This patient was taking zolpidem frequently for long time and in supratherapeutic doses and he became dependant on it and had a withdrawal seizure after 48 hours of its abstinence. Expand
...
1
2
3
4
5
...